Novartis Ireland was shortlisted for the AI Innovation of the Year Award at the Digital Transformation & AI Awards 2025, put forward last year for an initiative that brought generative AI into a high-compliance, regulated environment where the standards applied to data accuracy, reporting, and documentation left little room for error and even less for experimentation without rigorous justification.

The initiative demonstrated that deploying AI in such a setting required a level of innovative thinking and structured problem solving that went well beyond standard implementation practice. By working through the specific compliance constraints governing its quality event management process, Novartis Ireland developed an approach that allowed generative AI to operate effectively within regulatory boundaries rather than around them.

The outcomes reflected the quality of that groundwork. Data insights improved, reporting became more reliable, documentation quality was enhanced, and the time previously absorbed by manual processing was meaningfully reduced. These results gave the judging panel clear, evidence-backed confirmation of the initiative's operational value.

The Digital Transformation & AI Awards recognises organisations driving evidence-based digital change across Irish enterprise and public life. The AI Innovation of the Year category assessed entries on the transformative nature of the innovation, measurable impact, scalability potential, and contribution to broader organisational and societal goals.

Novartis Ireland's inclusion on the shortlist placed it among the cohort the judging panel identified as setting a credible standard for responsible AI application in Ireland's life sciences sector.

For more information on finalists, past winners, and judging insights, visit the official Digital Transformation & AI Awards website.